BRATISLAVA \u2013 Slovensk\u00e9 onkof\u00f3rum \u010del\u00ed v\u00e1\u017enej kr\u00edze. \u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div (\u0160\u00daKL) vydal v kr\u00e1tkom \u010dase dve alarmuj\u00face spr\u00e1vy o nedostatku k\u013e\u00fa\u010dov\u00fdch liekov pou\u017e\u00edvan\u00fdch pri lie\u010dbe rakoviny a autoimunitn\u00fdch ochoren\u00ed. V\u00fdpadky hl\u00e1sia lieky Holoxan a Endoxan, pri\u010dom technick\u00e9 probl\u00e9my u hlavn\u00e9ho eur\u00f3pskeho v\u00fdrobcu ochromili dod\u00e1vky pre cel\u00fa \u00daniu.<\/p>\n
Spolo\u010dnos\u0165 Baxter, ktor\u00e1 je k\u013e\u00fa\u010dov\u00fdm dod\u00e1vate\u013eom onkologick\u00fdch lie\u010div v E\u00da, \u00a0ozn\u00e1mila po dohode s Eur\u00f3pskou liekovou agent\u00farou (EMA) preru\u0161enie v\u00fdroby hne\u010f dvoch z\u00e1sadn\u00fdch liekov: Holoxanu a Endoxanu.<\/p>\n
D\u00f4vodom s\u00fa technick\u00e9 obmedzenia u zmluvn\u00e9ho v\u00fdrobcu a n\u00e1pravn\u00e9 opatrenia po regula\u010dnej in\u0161pekcii. Hoci sa v\u00fdroba v z\u00e1vodoch u\u017e op\u00e4tovne rozbieha, v\u00fdpadok v dod\u00e1vkach bude trva\u0165 dlh\u00e9 mesiace. Pri Endoxane sa nedostatok o\u010dak\u00e1va a\u017e do tretieho \u0161tvr\u0165roka 2026. Pri Holoxane je situ\u00e1cia e\u0161te kritickej\u0161ia, v\u00fdpadok m\u00f4\u017ee pretrv\u00e1va\u0165 a\u017e do za\u010diatku roka 2027.<\/p>\n
Oba lieky patria medzi tzv. cytostatik\u00e1 a pou\u017e\u00edvaj\u00fa sa na lie\u010dbu \u0161irokej \u0161k\u00e1ly ochoren\u00ed:<\/p>\n
\n\tEndoxan: K\u013e\u00fa\u010dov\u00fd pri hematologick\u00fdch malignit\u00e1ch (napr. leuk\u00e9mie), sol\u00eddnych n\u00e1doroch, ale aj pri pr\u00edprave pred transplant\u00e1ciou kostnej drene \u010di lie\u010dbe v\u00e1\u017enych autoimunitn\u00fdch chor\u00f4b.
\n\tHoloxan: Pou\u017e\u00edva sa pri lie\u010dbe sark\u00f3mov, lymf\u00f3mov \u010di n\u00e1dorov semenn\u00edkov u det\u00ed aj dospel\u00fdch.
<\/p>\n
Pr\u00edsne opatrenia v nemocniciach<\/p>\n
Lek\u00e1ri a zdravotn\u00edcki pracovn\u00edci dostali od \u0160\u00daKL jasn\u00e9 in\u0161trukcie, ako zvl\u00e1dnu\u0165 toto kr\u00edzov\u00e9 obdobie. Pred za\u010dat\u00edm lie\u010dby u ka\u017ed\u00e9ho nov\u00e9ho pacienta musia preveri\u0165, \u010di maj\u00fa v sklade dostatok z\u00e1sob na dokon\u010denie cel\u00e9ho lie\u010debn\u00e9ho cyklu. Pri lieku Endoxan existuje mal\u00e1 n\u00e1dej \u2013 na rozdiel od Holoxanu s\u00fa na trhu aj in\u00ed dod\u00e1vatelia, ktor\u00ed by mohli v\u00fdpadok \u010diasto\u010dne vykry\u0165. Dobrou spr\u00e1vou je tie\u017e fakt, \u017ee Endoxan vo forme tabliet nie je t\u00fdmto v\u00fdpadkom zasiahnut\u00fd a zost\u00e1va pre pacientov dostupn\u00fd.<\/p>\n
\u0160\u00daKL zd\u00f4raz\u0148uje, \u017ee aktu\u00e1lna situ\u00e1cia nes\u00favis\u00ed s kvalitou alebo bezpe\u010dnos\u0165ou liekov. Pacienti, ktor\u00ed maj\u00fa liek doma alebo ho pr\u00e1ve dost\u00e1vaj\u00fa v nemocnici, sa nemusia ob\u00e1va\u0165 o jeho \u00fa\u010dinnos\u0165. Probl\u00e9mom je v\u00fdhradne to, \u017ee lieku sa v Eur\u00f3pe moment\u00e1lne vyr\u00e1ba a distribuuje pr\u00edli\u0161 m\u00e1lo na to, aby pokryl potreby v\u0161etk\u00fdch pacientov.<\/p>\n
Ak vy alebo v\u00e1\u0161 bl\u00edzky podstupujete onkologick\u00fa lie\u010dbu t\u00fdmito prepar\u00e1tmi, odpor\u00fa\u010da sa konzult\u00e1cia s o\u0161etruj\u00facim onkol\u00f3gom. Lek\u00e1ri maj\u00fa k dispoz\u00edcii medzin\u00e1rodn\u00e9 usmernenia, ako v pr\u00edpade tot\u00e1lneho nedostatku prejs\u0165 na alternat\u00edvne lie\u010debn\u00e9 re\u017eimy.<\/p>\n","protected":false},"excerpt":{"rendered":"BRATISLAVA \u2013 Slovensk\u00e9 onkof\u00f3rum \u010del\u00ed v\u00e1\u017enej kr\u00edze. \u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div (\u0160\u00daKL) vydal v kr\u00e1tkom \u010dase dve…\n","protected":false},"author":2,"featured_media":38325,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[16782,16781,43,40,44,39,42,45,41,1029],"class_list":{"0":"post-38324","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-slovensko","8":"tag-endoxan","9":"tag-holoxan","10":"tag-sk","11":"tag-slovak","12":"tag-slovak-republic","13":"tag-slovakia","14":"tag-slovencina","15":"tag-slovenska-republika","16":"tag-slovensko","17":"tag-sukl"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/116363318127755351","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/38324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=38324"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/38324\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/38325"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=38324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=38324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=38324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}